Use of crystallized phenol in pilonidal sinus, in the pediatric age group, 5-year single surgeon experience

Abstract Objective: The Pilonidal Sinus (PS) is a pathology of the gluteal cleft that occurs with acute or chronic infection. This study aimed to report the evaluation of five-year experience with 50 patients’ data outcomes of crystallized phenol in pilonidal sinus treatment (CP) pediatric age group. Methods: This retrospective study included 50 patients who underwent CP between 2017 and 2023 years. Patient demographics, operative data, follow-up findings, complications, and recurrence data were also evaluated. Results: Fifty patients (female:31, male:19), mean of age 15,4 years. Hirsutism was diagnosed in 10 female patients (20%). Sixteen (32 %) patients had a family history of PS. Five patients had a smoking habit history (%10). The form of anesthesia was local anesthesia in eight patients (16%), sedation and local anesthesia in 27 patients (54%), and spinal anesthesia in 15 patients (30%). The average duration of the procedure was 13,8 min (10–22 minutes). The mean postoperative leakage time were 6,6 days. Complications were observed in five patients. (10%). Recurrence was observed in three patients (6%). The overall cure rate is 94%. Conclusion: The CP procedure should be used as the first choice, especially in adolescents, compared to the primary method in PS, such as total sinus excision, due to its minimally invasive, painless, low risk of recurrence, and very short postoperative recovery time.